Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Alexandria Journal of Pharmaceutical Sciences. 1991; 6 (1): 65-67
en Inglés | IMEMR | ID: emr-18949

RESUMEN

Amitriptyline, a tricyclic anti-depressant, was tested for its antimuscarinic and antihistaminic effects against bethanechol and histamine-stimulated gastric secretion in male rats. Daily intramuscular injection of Amitriptyline [5 mg/kg body weight] for two weeks proved to be effective only in inhibiting bethanechol-stimulated gastric secretion. Amitriptyline produced a significant reduction in both free and total acidity of the gastric juice, with significant increase in mucin content, but no change in its peptic activity. The role of Amitriptyline in blocking Bethanechol-stimulated gastric secretion may suggest that the ulcer healing is caused by its anticholinergic activity


Asunto(s)
Amitriptilina/farmacología
2.
Alexandria Journal of Pharmaceutical Sciences. 1990; 4 (1): 46-49
en Inglés | IMEMR | ID: emr-15218

RESUMEN

After 3 weeks of daily intraperitoneal [i.p.] administration of cholorpromazine [10 mg/kg] or metoclopramide [0.15 mg/kg] to male rats, the whole brain levels of norepinephrine and dopamine significantly decreased. Serum prolactin, thyroxine and tri-iodothyronine levels significantly increased as compared to control values. Serotonin and ACTH were affected by chlorpromazine only. Brain histamine level did not change in both groups. It was concluded that drugs which after central dopaminergic mechanisms may exert significant influences on the secretion of some adenohypophyseal hormones. Serotonin may partially counteract the effect of dopamine. Brain histamine is unlikely to contribute in an important way to the major action of chlorpromazine and metoclopramide in the secretion of hormones


Asunto(s)
Metoclopramida/farmacología , Hormonas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA